Clinical Trials on 利斯的明毒性 in China
总计74个结果
-
The First Affiliated Hospital with Nanjing Medical...Baxter Healthcare Corporation未知
-
Peking University Third Hospital尚未招聘
-
Huashan HospitalChildren's Hospital of Fudan University; Shanghai Children's Hospital; Shanghai Children's Medical... 和其他合作者招聘中
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International Hospital完全的
-
The Hong Kong Polytechnic UniversityRuijin Hospital招聘中
-
Peking University People's HospitalXijing Hospital; Peking Union Medical College Hospital; Chinese PLA General Hospital; Peking University... 和其他合作者撤销
-
Peking Union Medical College Hospital未知
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
Shanghai Zhongshan HospitalWu Jieping Medical Foundation未知
-
Guangdong Provincial Hospital of Traditional Chinese...完全的
-
Guangdong Provincial Hospital of Traditional Chinese...完全的
-
Sun Yat-sen UniversityFirst People's Hospital of Foshan; The First Affiliated Hospital, Guangzhou University of Traditional... 和其他合作者招聘中
-
Guangdong Provincial Hospital of Traditional Chinese...Peking Union Medical College Hospital尚未招聘
-
Guangdong Provincial Hospital of Traditional Chinese...完全的
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...未知
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...未知
-
Cancer Institute and Hospital, Chinese Academy...招聘中化疗毒性 | 放射治疗;并发症 | PARP抑制剂 | 免疫检查点抑制剂 | 曲妥珠单抗 | 乳腺癌,家族性男性 | CDK4/6 抑制剂 | 帕妥珠单抗中国
-
Peking University People's HospitalPeking University; Northwestern University未知对 Famitinib 和 Camrelizumab 的耐药性 | 疗效和毒性的生物标志物中国
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Cancer Institute and Hospital, Chinese Academy...未知
-
Cancer Institute and Hospital, Chinese Academy...未知
-
Peking University People's HospitalPeking University Shougang Hospital; Jiangsu HengRui Medicine Co.招聘中